Showing results (101-110 of 113) with videos related to
Sort By:
Pageof 12
International Journal of Radiation Oncology, Biology, Physics|July 20, 2007
Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observationsPeter J Hoskin, Dawn M Carnell, N Jane Taylor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancerMei-Lin W Ah-See, Andreas Makris, N Jane Taylor, et al.Anatomical Record (Hoboken, N.J. : 2007)|October 5, 2020
Cranial synchondroses of primates at birthTimothy D Smith, Rebecca L Reynolds, Nanami Mano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2012
Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancerPaul Nathan, Martin Zweifel, Anwar R Padhani, et al.Forensic Science International. Synergy|June 30, 2021
The search process: Integrating the investigation and identification of missing and unidentified personsMercedes Salado Puerto, Denise Abboud, Jose Pablo Baraybar, et al.BMJ Open|November 9, 2022
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)Jim Zhong, Sarah Brown, Maria Serra, et al.Radiology|October 2, 2019
Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response MarkerJessica M Winfield, Jennifer C Wakefield, David Dolling, et al.Frontiers in Psychiatry|April 17, 2026
Commercial or industrial use of mental health data for research: primer and best-practice guidelines from the DATAMIND patient/public Lived Experience Advisory GroupLinda A Jones, Corrine Barber, Naomi Clements-Brod, et al.The Oncologist|March 22, 2015
Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumorsChooi Peng Lee, N Jane Taylor, Gerhardt Attard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomasTim Meyer, Andrew M Gaya, Gairin Dancey, et al.Pageof 12